| Stage | VREX | % of rev | OEC | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $211M | 100.00% | $501M | 100.00% | OEC ×2.38 |
| Gross profit | $77M | 36.44% | $93M | 18.57% | VREX +17.9pp |
| Operating income | $23M | 10.83% | $21M | 4.25% | VREX +6.6pp |
| Pre-tax income | $16M | 7.70% | $5M | 1.00% | VREX +6.7pp |
| Net income | $16M | 7.55% | $2M | 0.36% | VREX +7.2pp |
| Stage | VREX | OEC | Gap · A − B |
|---|---|---|---|
| Revenue | $211M100.00% | $501M100.00% | OEC ×2.38 |
| Gross profit | 36.44%$77M | 18.57%$93M | VREX +17.9pp |
| Operating income | 10.83%$23M | 4.25%$21M | VREX +6.6pp |
| Pre-tax income | 7.70%$16M | 1.00%$5M | VREX +6.7pp |
| Net income |
| 7.55%$16M |
| 0.36%$2M |
| VREX +7.2pp |
No shared counterparties.